Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis

被引:0
|
作者
Yin, Cong [1 ]
Li, Juan [1 ,3 ]
Yuan, Lin [2 ]
机构
[1] Hubei Univ Chinese Med, Hubei Prov Key Lab Tradit Chinese Med Resource & C, Wuhan, Hubei, Peoples R China
[2] Hubei Minzu Univ, Hubei Prov Key Lab Occurrence & Intervent Rheumat, Enshi, Hubei, Peoples R China
[3] Hubei Univ Chinese Med, Coll Pharm, Hubei Prov Key Lab Tradit Chinese Med Resource & C, Huang Jia Hu West Rd 16, Wuhan 430065, Hubei, Peoples R China
关键词
D O I
10.1002/clc.23994
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:584 / 584
页数:1
相关论文
共 50 条
  • [31] Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure
    Kociol, Robb D.
    McNulty, Steven E.
    Hernandez, Adrian F.
    Lee, Kerry L.
    Redfield, Margaret M.
    Tracy, Russell P.
    Braunwald, Eugene
    O'Connor, Christopher M.
    Felker, G. Michael
    CIRCULATION-HEART FAILURE, 2013, 6 (02) : 240 - 245
  • [32] Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
    Okada, Tomoaki
    Miyoshi, Toru
    Oka, Akihiro
    Tsushima, Ryu
    Sudo, Yuya
    Seiyama, Kosuke
    Takagi, Wataru
    Kawaguchi, Tomohiro
    Ozaki, Masatomo
    Sogo, Masahiro
    Ugawa, Satoko
    Nosaka, Kazumasa
    Takahashi, Masahiko
    Okawa, Keisuke
    Doi, Masayuki
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [33] Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
    Chatterjee, Saurav
    Biondi-Zoccai, Giuseppe
    Abbate, Antonio
    D'Ascenzo, Fabrizio
    Castagno, Davide
    Van Tassell, Benjamin
    Mukherjee, Debabrata
    Lichstein, Edgar
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [34] Effect of tolvaptan on long-term prognosis in Japanese patients with heart failure: a systematic review and meta-analysis
    Nakao, Y.
    Saito, M.
    Yamaguchi, O.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1027 - 1027
  • [35] Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction
    Matsue, Yuya
    Suzuki, Makoto
    Torii, Sho
    Yamaguchi, Satoshi
    Fukamizu, Seiji
    Ono, Yuichi
    Fujii, Hiroyuki
    Kitai, Takeshi
    Nishioka, Toshihiko
    Sugi, Kaoru
    Onishi, Yuko
    Noda, Makoto
    Kagiyama, Nobuyuki
    Satoh, Yasuhiro
    Yoshida, Kazuki
    Goldsmith, Steven R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 188 - 193
  • [36] Use of tolvaptan vs. furosemide in older patients with heart failure Meta-analysis of randomized controlled trials
    Huang, W. -I.
    Yang, Y.
    Yang, J.
    Yang, J.
    Wang, H. -b.
    Xiong, X. -I.
    Zhang, Y. -f.
    HERZ, 2018, 43 (04) : 338 - 345
  • [37] PROGNOSIS IMPACT OF NUTRITIONAL STATUS IN PATIENTS WITH ACUTE HEART FAILURE: META-ANALYSIS
    Belayachi, Jihane
    Katir, Imane
    Benammi, Sarah
    Bennis, Rhita Nechba
    Madani, Naoufal
    Abouqal, Redouane
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 176 - 176
  • [38] Efficacy and safety of levosimendan in patients with acute right heart failure: A meta-analysis
    Qiu, Jiayong
    Jia, Lei
    Hao, Yingying
    Huang, Shenshen
    Ma, Yaqing
    Li, Xiaofang
    Wang, Min
    Mao, Yimin
    LIFE SCIENCES, 2017, 184 : 30 - 36
  • [39] Ultrafiltration for patients with acute decompensated heart failure A systematic review and meta-analysis
    Wang, Meng-jun
    Zheng, Yan-mei
    Jin, Hong-xu
    MEDICINE, 2021, 100 (50) : E28029
  • [40] The safety of morphine in patients with acute heart failure: A systematic review and meta-analysis
    Zhang, Dandan
    Lai, Wei
    Liu, Xiao
    Shen, Yang
    Hong, Kui
    CLINICAL CARDIOLOGY, 2021, 44 (09) : 1216 - 1224